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Signal transducer and activator of transcription (STAT) proteins are normally long-lived, but infection with certain
Paramyxoviruses results in efficient loss of IFN-responsive STAT1 or STAT2. Expression of a virus-encoded protein called “V”
is sufficient to mediate the destruction of STAT proteins. STAT degradation is blocked by proteasome inhibitors, strongly
implicating the ubiquitin (Ub)-proteasome targeting system. We demonstrate that cellular expression of V proteins from
simian virus 5 (SV5) and type II human parainfluenza virus (HPIV2) induces polyubiquitylation of STAT1 and STAT2 targets.
In vitro, the V proteins catalyze Ub transfer in an ATP-dependent process that requires both Ub-activating (E1) and
Ub-conjugating (E2) activities. Furthermore, SV5 and HPIV2 V-interacting protein partners were isolated by affinity purification
from human cells and reveal a complex of associated cellular proteins. This complex includes both STAT1 and STAT2, and
the damaged DNA binding protein, DDB1. In addition, a protein related to a family of cellular Ub ligase complex subunits, cullin
4A (Cul4A), associated with the V proteins. The roles of both DDB1 and Cul4A in STAT1 degradation by SV5 infection were
analyzed using small interfering RNAs. These findings demonstrate the assembly of a V-dependent degradation complex that
includes STAT1, STAT2, DDB1, and Cul4A. In agreement with prior nomenclature on SCF-type cellular E3 enzymes, we referB1; culKey Words: paramyxovirus; V protein; STAT1; STAT2; DD
Introduction. The intracellular signaling system used
by type I IFN to establish a cellular antiviral state involves
activation of latent signal transducer and activator of
transcription (STAT) proteins, STAT1 and STAT2 by ty-
rosine phosphorylation. The STAT proteins heterodimer-
ize and combine with a third protein, interferon regula-
tory factor 9 (IRF9) to form the heterotrimeric transcrip-
tion factor, ISGF3. Activated ISGF3 translocates to the
nucleus and binds specific DNA IFN-stimulated re-
sponse element (ISRE) sequences in the promoters of
antiviral target genes, increasing their transcription rate
(reviewed in 1, 2). The nuclear accumulation of activated
STAT transcription factors is transient, and attenuation of
STAT protein activity is associated with nuclear tyrosine
dephosphorylation (3–6). Following dephosphorylation,
the STAT proteins are recycled to the cytoplasm, where
they are able to participate in subsequent signaling ac-
tivation cycles (7–9). As the regulation of STAT proteins is
by a phosphorylation/dephosphorylation cycle, both
STAT1 and STAT2 are very stable (5, 10, 11).
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Despite the long half-life of cellular STAT proteins,
infection of cells with some negative-strand RNA viruses
in the Rubulavirus genus results in rapid and efficient
degradation of STAT proteins (11–13). The adaptation for
STAT destruction provides the viruses with a means of
evading the IFN-induced antiviral response, the innate
immune response driven by ISGF3. For simian virus 5
(SV5) and mumps virus, STAT1 is targeted, but for type II
human parainfluenza virus (HPIV2), STAT2 is the primary
proteolytic target. These anti-STAT actions are mediated
by a single virus-encoded protein called “V”, that is both
necessary and sufficient to mediate STAT degradation
and inhibit IFN signaling (11, 12, 14). The STAT targeting
mechanism remains to be completely elucidated, but the
V-mediated degradation is posttranslational and blocked
by drugs that inhibit the cellular proteasome (11, 12). The
paramyxovirus V proteins have no amino acid sequence
homology to known cellular proteins, but are highly iden-
tical to each other within a C-terminal domain that con-
tains seven conserved cysteine residues (15). The V
protein is a metalloprotein, and the conserved cysteine
residues are required for binding 2 mol zinc per mole of
protein (16). Although similar in metal-binding stoichiom-
etry, the conserved V protein domain is distinct in aminoto this complex as VDC. © 2002 Elsevier Science (USA)
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from any other known zinc-binding proteins, including
RING domains and zinc fingers (17). In addition to their
STAT targeting ability, the V proteins of SV5 and HPIV2
have been shown to interact with the DDB1/p125 subunit
of a cellular damaged DNA-binding factor (DDB). DDB is
critical for global genomic repair as well as UV excision
repair, and a second subunit, DDB2/p48, is mutated in
xeroderma pigmentosum group E patients (see ref. 18
and citations therein). DDB1 also interacts with a non-
structural protein from the hepatitis B virus (HBx) (19).
The significance of DDB1 binding for SV5 has been
linked with multiple cell-cycle changes that occur down-
stream of SV5 infection or V protein expression, and
these alterations can be partially alleviated by DDB1
overexpression (20). Recent work combining somatic cell
genetics with biochemical analysis has revealed that
these V proteins function to nucleate the assembly of
multiprotein complexes that include at least V, STAT1,
and STAT2, but are entirely independent of IFN signal
transduction (13). The essential role for STAT2 in SV5-
induced STAT1 degradation was further reinforced by the
discovery that the species-specific failure of SV5 to de-
grade STAT1 and antagonize IFN signaling in mouse
cells is due to amino acid sequence differences in the
murine STAT2 orthologue (21).
The evidence for a V-induced STAT-targeting complex
in combination with the circumstantial evidence suggest-
ing that V proteins utilize the proteasome for STAT deg-
radation provided a hypothesis that the V protein might
work alone or in combination with host cell factors to
produce a ubiquitin (Ub) ligase (E3) activity that recog-
nizes STAT protein substrates. Evidence is provided for
the V-dependent polyubiquitylation of STAT targets in
transfected cells. Furthermore, results indicate that the V
proteins of SV5 and HPIV2 possess intrinsic Ub ligase
activity that defines their function as E3 enzymes. V-
interacting proteins from human cells were identified by
affinity chromatography, and the V-dependent complexes
were found to assemble only in the presence of the
full-length V protein. Immunoblotting indicates that these
complexes include the known V-interaction partners
STAT1, STAT2, and DDB1, as well as a previously unrec-
ognized component, a protein identified as cullin 4A
(Cul4A) that is homologous to a family of proteins that are
essential components of cell cycle-regulating E3 com-
plexes. Interference with DDB1 and Cul4A using specific
small interfering RNA (siRNA) reagents reduced the effi-
ciency of STAT1 targeting by SV5 infection. Together,
these data define the E3 ubiquitin ligase activity of V
proteins as an amalgam of intrinsic viral activities and
virus-appropriated cellular activities that combine to tar-
get STAT proteins for proteasomal degradation.
Results. V protein expression induces polyubiquityla-
tion of STAT targets. Experiments using pharmacological
inhibitors have strongly implicated the proteasome as
the primary vehicle of STAT proteolysis downstream of
paramyxovirus infection or V protein expression (11, 12).
The usual signal for proteasome targeting is a poly-(Ub)
chain, but no such polyubiquitylation of STAT substrates
has been previously observed in SV5- or HPIV2-infected
cells or in high-efficiency V protein expression systems.
Therefore, to examine the ability of V to induce STAT
ubiquitylation, V proteins were expressed in 293T cells
using plasmid transfection conditions that produced V
protein levels suboptimal for degradation to improve the
capture of the unstable polyubiquitylated STAT interme-
diates. Immunoprecipitation of the target STAT protein
followed by immunoblot with antiserum specific for Ub
revealed V-dependent target polyubiquitylation (Fig. 1).
Cells expressing SV5 V-induced polyubiquitin modifica-
tion of STAT1, and HPIV2 V-induced polyubiquitin modifi-
cation of STAT2, consistent with their targeting specific-
ities. This result demonstrates that expression of
Paramyxovirus V proteins can stimulate an activity that is
similar to cellular Ub-ligase (E3) enzymes that is directed
toward their normally long-lived STAT substrates.
V protein has intrinsic E3 activity. Protein substrates
are targeted for proteasomal degradation in three enzy-
matic steps (22). E1 proteins activate Ub in an ATP-
dependent reaction and transfer the activated Ub to E2
or Ub-conjugating enzymes. In conjunction with the E2,
an E3 Ub-ligase activity facilitates substrate-specific
transfer of Ub to the target. In vitro systems for E3 activity
often rely on substrate-independent Ub transfer, result-
ing in nonphysiological autoubiquitylation that is consid-
ered mechanistically meaningful (23). Given the similarity
of zinc-binding stoichiometry between the C-terminal do-
main of V proteins and RING domains (2:1 molar ratio)
(17) that are often present in a class of cellular E3
complexes, the genetic and biochemical evidence dem-
onstrating that the V proteins can bind to their STAT
targets, and the ability of V to catalyze STAT polyubiqui-
tylation and degradation, the intrinsic E3 activity of V
proteins was tested. Defined in vitro reactions were
prepared in which purified, bacterially expressed GST or
GST-SV5 V proteins were mixed with E1, E2, ATP, and
biotinylated Ub. After incubation, separation by SDS–
PAGE, and transfer to nitrocellulose filters, probing with
FIG. 1. V protein expression induces STAT target polyubiquitylation.
293T cells were transfected with empty vector () or expression vector
for SV5 V (SV) or HPIV2 V (HV). Whole-cell extracts were immunopre-
cipitated (IP) with antiserum for STAT1 or STAT2, and then subject to
Western blot (WB) with antiserum for STAT1, STAT2, or ubiquitin (Ub).
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streptavidin-conjugated secondary antibody revealed the
pattern of newly ubiquitylated species (Fig. 2A). Weak
nonspecific bands were present in both GST control and
GST-SV5 V reactions, but the GST-SV5 V reaction also
contained strongly reactive ubiquitylated species with
apparent molecular weights of 40 and 60 kDa. Alignment
and comparison of the biotin-avidin blot with amido black
staining of the same membrane (Fig. 2A) revealed that
while the Ub-reactive species were in low abundance,
the 60-kDa species differed from the bulk of the GST-SV5
V protein by approximately 6–10 kDa, consistent with the
predicted size of a monoubiquitylated form of the GST-
SV5 V fusion protein. The 40 kDa might represent an
unrelated substrate protein present at low levels in the
purified protein preparation, Ub-charged E2, or more
likely, a copurified degradation product of GST-SV5 V
protein. Protease digestion mapping experiments (not
shown) revealed that the site of Ub attachment resides in
the GST carrier portion and 40 kDa is in the range of
mobility expected for a monoubiquitylated GST fragment.
To determine the generality of the in vitro Ub transfer
experiment and to define the nature of the Ub transfer as
an E3 activity, additional reactions were performed with
GST, GST-SV5 V, and GST-HPIV2 V (Fig. 2B). The two
GST-V proteins exhibited distinct patterns of in vitro Ub
transfer, consistent with the different molecular weights
and quality of the two GST fusion protein preparations,
and the Ub transfer reaction absolutely required ATP, as
well as E1 and E2 (Fig. 2B). By these criteria, the V proteins
represent a new class of viral Ub ligase enzymes that
satisfy a minimal definition of E3 enzymatic activity.
In vitro E3 activity from V protein immune complexes.
The E3 activity of the GST-V proteins did not fully reca-
pitulate the activity of V protein expression in cells. For
example, it is generally accepted that most proteasome
targeting is mediated by polyubiquitin rather than mono-
ubiquitin modifications. Additionally, biochemical and ge-
netic data demonstrate a requirement for both STAT1 and
STAT2 proteins in SV5 and HPIV2-dependent degrada-
tion systems (13). Therefore, we examined the ability of V
proteins immunoprecipitated from mammalian cells to
support target ubiquitylation in vitro. In agreement with
the results shown in Fig. 1, the affinity-purified SV5 V-
dependent complex contains detectable amounts of
ubiquitin-modified STAT1, and the HPIV2 V-dependent
complex contains modified STAT2 (Fig. 2C). Analysis of
the immune complexes with in vitro reaction conditions
as used for the GST fusion proteins resulted in an in-
crease in the amount of modified STAT target, indicating
that the purified V-associated complex contains E3 ac-
tivity. Reprobing the blots with antiserum to ubiquitin
verified the E3 activity of the immune complexes, as
illustrated by increased polyubiquitin conjugates in lanes
containing E1, E2, and ATP. Interestingly, although E1
enzyme was required, reactions lacking exogenous E2
enzyme could support some ubiquitin transfer activity.
This finding demonstrates that the immuno-affinity-puri-
fied V-dependent complex contains E3 activity that can
increase STAT modification in vitro and might also con-
tain a cellular E2 activity.
A complex of cellular proteins interact with V. The
intrinsic E3 Ub ligase activity of bacterially expressed
GST-V proteins only partially accounts for the STAT tar-
geting activity observed in vivo, which is known to in-
volve a complex of cellular proteins (13). To identify
cellular proteins that interact with V and might participate
in STAT degradation, FLAG epitope tag affinity chroma-
tography was utilized. Analysis of the affinity-purified
material by SDS–PAGE and silver staining revealed a
number of V-interacting protein (VIP) species that ranged
in apparent molecular weight between 55 and 300 kDa
that copurified with either HPIV2 V or SV5 V protein but
not a FLAG-tagged GFP control (Fig. 3A). The cellular
proteins comprise a V-dependent complex (VDC) that is
strikingly similar between the two viral proteins and may
represent a core degradation complex. Additional virus-
specific protein partners were also identified, which may
be involved in either degradation targeting specificity or
other unrelated functions of the V proteins. Our previous
analysis defined a role for both STAT1 and STAT2 in the
virus degradation reaction and their presence in the
affinity purified material was tested by immunoblotting.
Both STAT1 and STAT2 were detected in the VDC (Fig.
3b). STAT1 antiserum reacted with a protein similar in
FIG. 2. Ubiquitin ligase activity of V proteins. (A) In vitro assay for E3
activity. GST or GST-SV were incubated with ATP, E1, E2, and biotinyl-
ated ubiquitin (Ub) for 90 min and then processed for Western blot
using streptavidin-horseradish peroxidase. Left: Biotinylated Ub profile.
Right: Amido black stain of the same membrane to reveal the total
protein pattern. (* is used to indicate Ub-containing species.) (B) ATP,
E1, and E2 requirement. In vitro reactions were assembled with () or
without () components indicated followed by blotting as in (A). (C) E3
assays carried out with cellular immune complexes. Left: Lysates from
293T cells prepared as in Fig. 1 were immunoprecipitated with FLAG
affinity resin and subject to in vitro E3 assays on the beads with
components indicated and probed with anti-STAT antisera. Right: Blots
were reprobed with anti-Ubiquitin antiserum.
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size to VIP90, while STAT2 antiserum reacted with a
protein in the vicinity of VIP125b. Neither STAT was de-
tected with GFP controls, confirming specificity in our
system. The most prominent of the associated proteins
detected by silver stain, designated VIP125a, is repre-
sented in nearly equivalent stoichiometric amounts to
the V proteins, as estimated by silver staining intensity.
The abundance and electrophoretic mobility of VIP125a
suggested that it might represent the previously identi-
fied V protein interaction partner, DDB1. Immunoblotting
with antiserum specific for DDB1 confirmed the identity
of VIP125a as DDB1. As a member of the DDB complex,
DDB1 interacts with a second protein, DDB2. No detect-
able DDB2 signal was identified by immunoblotting with
specific antiserum (not shown).
Another interaction partner of DDB1 is Cul4A, a protein
related to the cullin family required for cell-cycle regula-
tion (24). Cullins are key structural components of sev-
eral multiple-subunit cellular E3 complexes (25, 26), sug-
gesting a possible link between DDB1 and E3 activity.
Probing the affinity-purified preparations with antiserum
specific for Cul4A reacted strongly with several closely
migrating bands in the VIP75-85 region. The exact com-
position of these multiple species varied slightly be-
tween individual preparations and are consistent with
the observed modification of cullin proteins by the Ub-
like NEDD8 that is requisite for their full catalytic activity
(27). These results indicate that in addition to the V
protein, STAT1, and STAT2, the VDC contains DDB1 and
Cul4A.
The V protein cysteine-rich C-terminal domain has
been demonstrated to be essential for interactions with
DDB1, as well as the STAT destroying activity of
Paramyxoviruses. In an attempt to map the regions of the
V protein to which individual VIPs bind, affinity purifica-
tion experiments were carried out with FLAG-tagged N-
or C-terminal V protein fragments. Conspicuously, gel
electrophoresis and silver staining did not reveal the
same patterns of VIP complexes in the eluates from N- or
C-terminal V protein fragments, but interestingly, VIP68
binding appeared to be enhanced by the N-terminal
fragments (Fig. 3C). More sensitive examination of
STAT1, STAT2, DDB1, and Cul4A by immunoblot revealed
that none of these VIPs were efficiently recruited by
either the N- or C-terminal V protein fragments. Possibly
related to the observation that V protein N-terminal do-
mains are natively unfolded (28), these results demon-
strate that VDC assembly requires a combination of N-
and C-terminal determinants that are insufficient on their
own to nucleate complex formation. Thus it is likely that
multiple protein–protein interactions determine the as-
sembly of VDC.
DDB1 and Cul4A contribute to SV5-induced STAT1
degradation. The affinity chromatography indicates a
number of cellular proteins can bind to V proteins; these
VIPs might participate in STAT degradation or carry out
other roles in virus replication. To evaluate the participa-
tion of DDB1 and Cul4A in the degradation of STAT1, their
steady-state expression levels were reduced by double-
stranded RNA interference. Small interfering RNA du-
plexes were designed to specifically target either DDB1
or Cul4A. Following SV5 infection, lysates were probed
for STAT1 protein. SV5 infection eliminated STAT1 in the
absence of siRNA, but interference with either DDB1 or
Cul4A protected STAT1 from SV5-induced degradation
(Fig. 4A). The effect with DDB1 interference was most
FIG. 3. Affinity purification of a V protein-dependent complex. (A)
Silver stain of the eluate from FLAG affinity purification. Migration
positions of prestained molecular weight markers (M) or V-interacting
protein (VIP) partners are indicated by their apparent molecular weight
in kDa. Control green fluorescent protein (GFP), FLAG-SV5V (SV), or
FLAG-HPIV2 V (HV) are indicated. (B) Serologic identification of VIP
subunits. Parallel samples from experiment in (A) were processed for
immunoblotting with antisera for DDB1, STAT2, STAT1, or Cul4A. (C)
Similar affinity preparations to (A) and (B). Silver stain (left) and immu-
noblotting (right) for SV, HV, and their respective N-terminal fragments
(SVN and HVN), or SV5 V C-terminal cysteine-rich domain (SVC).
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dramatic, with a 30–50% protection observed with as
little as 30 pmol siRNA. Interference with Cul4A pro-
duced a lesser degree of STAT1 protection, but 10–20%
protection was reproducibly observed with two separate
siRNA sequences. Nonspecific siRNA that targets the
firefly luciferase gene had no protective effect on STAT1,
confirming that siRNA effects were sequence-specific
(Fig. 4B). Immunoblotting demonstrates that DDB1 pro-
tein levels were reduced to approximately 30% of the
control level (Fig. 4C). Available antisera could not detect
Cul4A protein from total cell extracts, but Northern blot
analysis confirmed that siRNA could reduce the level of
Cul4A mRNA (Fig. 4D). This suggests that the minor
effect of Cul4A siRNA on STAT1 protection is not due to
inefficient removal, but rather, there may be redundancy
in the degradation system with respect to cullin function.
Importantly, none of the tested siRNAs prevented SV5
replication as evidenced by the equivalent accumulation
of virus-encoded P and V proteins under all conditions
(Fig. 4A).
Discussion. The results presented here indicate that
the STAT protein degradation catalyzed by the SV5 and
HPIV2 V proteins is mediated by a polyubiquitin targeting
signal. The finding of V-dependent STAT protein poly-
ubiquitylation produced the hypothesis that V acts as a
Ub ligase enzyme. Minimal in vitro assays demonstrate
that the V proteins have the intrinsic ability to carry out a
catalytic activity similar to that of cellular E3 Ub ligase
enzymes. Transfer of Ub in the minimal in vitro system
requires ATP, E1, and E2, and while this reaction mech-
anistically defines the V proteins as E3 enzymes, only a
limited rendition of V protein catalytic activity was ob-
served. However, in combination with extrinsic host cell
factors, V proteins are capable of copurifying STAT-di-
rected E3 activity, and in vitro dropout experiments indi-
cate the presence of an E2 activity in the immune com-
plex. In agreement with this host contribution to the E3
activity, the V protein was found to form associations with
several cellular components, including STAT1, STAT2,
DDB1, and Cul4A. The ability to efficiently nucleate these
factors (as well as other observed VIPs) relied on ex-
pression of a full-length V protein, suggesting that sev-
eral distinct protein interaction surfaces contribute to the
assembly of the degradation targeting complex.
We have adopted the term “VDC” to describe this
complex because it is an acronym for V-dependent com-
plex, virus-degradation complex, and V-DDB1-Cul4A and
satisfies the current nomenclature for the growing num-
ber of cellular SCF (for Skp1-cdc53-F box) E3 complexes
(25). Interestingly, these SCF type E3 complexes share
some similarities with the VDC described here. For ex-
ample, they all contain a cullin protein that apparently
serves a scaffolding role in E3 function (29). In addition to
cullins, the SCF complexes also contain a cysteine-rich
protein, typically in the form of a RING domain that
participates in binding the E2 enzyme. While the V pro-
tein cysteine-rich domain only superficially resembles
the RING domain in primary sequence, our results indi-
cate that the VDC does contain E2 activity (Fig. 2C).
Somatic cells harboring genetic deficiencies in either
STAT1 or STAT2 fail to support paramyxovirus-mediated
STAT targeting (13), and the siRNA results indicate that
DDB1 is also essential for STAT1 destruction by SV5.
Similar experiments with Cul4A demonstrated a less
dramatic effect on STAT1 destruction. This finding sug-
gests a less pivotal role for Cul4A in the VDC. Consid-
ering the relative abundance of DDB1 and Cul4A in our
VDC preparations, we speculate that DDB1 is at the
heart of the VDC and might redirect several redundant
cullin-based E3 activities toward STAT substrates. As
many SCF E3 activities directly regulate the cell cycle,
such a model would explain the multiple cell-cycle de-
fects described for SV5-infected or SV5 V-expressing
cells that are characterized by prolonged half-lives of
cyclins A, B, and E (20). Further elucidation of VDC
components will likely provide additional mechanistic
insights into regulation of the host cell by paramyxovi-
ruses.
FIG. 4. RNA interference with SV5-induced STAT1 degradation. Fi-
brosarcoma 2fTGH cells were transfected with small interfering RNA
(siRNA) duplexes for DDB1, Cul4A, or control siRNA which targets the
firefly luciferase gene (Ctrl) then infected with SV5 46 h later for 19 h.
siRNA (60 pmol) was used unless otherwise indicated. (A) Top: Immu-
noblot of 20 g total protein probed with antiserum for STAT1. ns 
nonspecific protein. Bottom: Same samples probed with monoclonal
antibody for an epitope in the shared N-terminus of SV5 P and V
proteins. (B) Sequence specificity of siRNA targeting. No inhibition of
STAT1 degradation with siRNA control. (C) DDB1 protein levels are
reduced by siRNA. Immunoblot probed with antiserum to DDB1. (D)
Top: Autoradiogram of Northern blot probed for Cul4A. Total RNA (30
g) separated by gel electrophoresis and transferred to nylon mem-
brane. Bottom: Total RNA detected by ethidium bromide staining. 28S
and 18S  ribosomal RNAs.
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Materials and Methods. Cell culture and plasmid trans-
fections. Human 293T cells were maintained and trans-
fected by standard calcium phosphate procedures as
described previously (13) using 2 g for each 6-cm plate
or 4 g for each 15-cm plate. Transfection of human
2fTGH cells for RNA interference is described below.
Expression plasmids pEF-FLAG-SV5-V and pEF-FLAG-
HPIV2-V have been described (13). The N-terminal con-
structs were made similarly by PCR amplification of the
gene region corresponding to amino acids 1–162 for both
V proteins, while the C-terminal constructs were made
from PCR of the region corresponding to the Cys-rich
V-domains; amino acids 162–222 for SV5-V, and 162–225
for HPIV2-V.
Immunoprecipitation and immunoblotting. Lysates
were prepared at 24 hpt in whole-cell extract buffer
(WCEB) and treated with 1 g/ml DNAse I for 2 h, and 50
g/ml ethidium bromide added before preclearing with
protein A agarose. Antibody–protein complexes formed
with specific antisera (anti-STAT1, Santa Cruz C-24;
anti-STAT2, Santa Cruz C20) were purified with protein A
beads and washed with WCEB. After elution with SDS,
proteins were separated by SDS–PAGE and processed
for immunoblotting (antibodies: monoclonal antiubiquitin,
Santa Cruz P4D1; STAT1 or STAT2, Santa Cruz; polyclonal
antiserum for-DDB1 or Cul4A (30), generous gifts of Dr.
Pradip Raychaudhuri, University of Illinois, Chicago) and
enhanced chemiluminescence.
Affinity purification. Lysates from four transfected
15-cm plates per sample (20 mg total protein per sam-
ple) were incubated with anti-FLAG(M2)-agarose beads
(100 l per sample; Sigma) overnight at 4°C. Beads were
washed with WCEB, and protein complexes eluted with
100 g/ml FLAG peptide. Eluates were denatured in SDS
loading buffer, separated by SDS–PAGE, and processed
for either silver staining (Biorad Silver Stain Plus kit) or
immunoblotting.
In vitro ubiquitylation assay. GST fusion proteins (GST,
GST-SV5-V, GST-HPIV2-V) (13) were grown in Escherichia
coli and purified with glutathione agarose beads by stan-
dard procedures (31). Prior to assays, quality and quan-
tity of fusion protein preparations were assessed by
spectrophotometry and SDS–PAGE Coomassie blue
staining patterns. For E3 assays, 30-l reactions were
assembled with 0.2 mM ATP, 40 ng E1 (rabbit, Calbio-
chem), 40 ng E2 (Cdc-34, Affiniti Research Products,
Ltd.), 2 g biotinylated ubiquitin (Affiniti), and5 g GST
or GST fusion protein in ubiquitylation buffer (50 mM Tris
pH 7.5, 2.5 mM MgCl2, 0.5 mM DTT). Reactions were
carried out both with and without an ATP-regenerating
system (1 mM creatine phosphate, 15 U creatine phos-
phokinase), except for E1, E2, and ATP drop-out experi-
ments, where no ATP-regenerating system was used,
and 1 g biotinylated Ub per reaction was used. Immune
complex reactions were similar, except 2 g ubiquitin
(Sigma) was used. Reactions were separated by 12%
SDS–PAGE and transferred to nitrocellulose for detection
with streptavidin horseradish peroxidase and enhanced
chemiluminescence or amido black.
RNA interference. Individual wells of a 24-well culture
dish containing 2fTGH cells (1  105 cells per well) were
transfected with siRNAs using the TransIT-TKO reagent
according the manufacturer’s recommendations (Mirus
Corp.). Transfection efficiency was 95–100%, as mea-
sured by GFP expression (not shown). Cells were in-
fected with 10 PFU/cell SV5 strain W3A (32, 13); lysates
were prepared, and 15 g protein were separated by
SDS–PAGE and processed for immunoblotting. Small in-
terfering RNAs were custom synthesized by Dharmacon
Research, Ltd. The following sequences were targeted:
DDB1: 5AACCUGUUGAUUGCCAAAAAC3; Cul4A: 5AA-
GAAGAUUAACACGUGCUGG3; Luciferase control: 5AA-
CGTACGCGGAATACTTCGA3.
Northern blot analysis. Total RNA isolation and North-
ern blot analysis were carried out by standard methods
(31). RNA (30 g) was separated on a 1% denaturing
agarose gel and probed with a Cul4A-specific probe
synthesized by random priming a 1.4-kB fragment of
Cul4A coding sequence in the presence of [-32P]ATP.
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